
According to the ICMR, the intervention arm of the trial will include baricitinib and the control arm will receive local standard of care. The trial will be initiated only after obtaining requisite regulatory and ethics approvals.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hXOVO9
via
IFTTT
0 comments:
Post a Comment